The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Ehizogie Edigin, MD: Outpatient Care Helps Reduce Hospitalizations for SLE Flare
In this video interview, Dr. Edigin talks about the importance of outpatient care in reducing hospitalizations for SLE flare.
Nathan den Broeder, MSs: Treating Rheumatoid Arthritis with Lower Doses of Rituximab
Nathan den Broeder, MSs, shares the findings of his study at the ACR 2021 Convergence.
Jing Cui, PhD: Identifying Risk Factors for Systemic Lupus Erythematosus
Research presented by Dr. Jing Cui at ACR 2021 Convergence identified significant risk factors for systemic lupus erythematosus in a risk prediction model study.
Ehizogie Edigin, MD, Discusses Racial Disparities Found in SLE Study
Research results shows that while overall hospitalization for SLE flare decreased, it increased among African American patients.
Jing Cui, PhD: SLE Risk Assessment Among Nurse Cohorts
Dr. Jing Cui speaks about how she examined lifestyle and environmental factors as well as genetic risk to assess risk of systemic lupus erythematosus.
Brepocitinib Improves Psoriatic Arthritis Outcomes at 16, 52 Weeks
The oral selective inhibitor showed significant benefit versus placebo at 2 different doses in the phase 2b trial.
Rheumatoid Arthritis Patients Adhere Better to Abatacept than TNF, JAK Inhibitors
A new ACR 2021 study suggests patients on the biologic may be less likely to discontinue treatment than those receiving other drug classes.
Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients
New phase 3 data show TX-102 SL from Tonix may benefit central sensitization in patients afflicted with fibromyalgia pain.
Remotely Delivered Cognitive-Behavioral, Exercise Care Benefits Rheumatic Fatigue
A pandemic-era study suggests rheumatology care teams can capably provide beneficial care via telemedicine to treatment-stable patients.
Rituximab Frequency Could Influence Rheumatic Patient Response to COVID-19 Vaccines
New ACR findings suggest patients taking the common biologic drug closely leading up to their vaccination may not have a humoral response to it.
Ehizogie Edigin, MD: SLE Flare Hospitalizations Decreased Over 2 Decades
In this interview, Dr. Edigin speaks about his longitudinal trend analysis that showed a decrease in SLE flare hospitalizations over the last 20 years.
Marla C. Dubinsky, MD: Finding Biomarkers in IBD
Patients with the absence of urgency had significantly greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.
Evan S. Dellon, MD: Dupilumab for EoE at ACG 2021
ACG represents the first major in-person conference since the COVID-19 pandemic.
Study Finds Race Irrelevant in COVID-19 Vaccine Acceptance Among IBD Patients
Even though COVID-19 infection disproportionately impacts minority patients, there’s no indication that vaccine intention differs depending on race in IBD patients.
Examining the Prevalence of Celiac Disease in Patients with Type 1 Diabetes Mellitus
This study found that compared with the general population, the prevalence of celiac disease in people with type 1 diabetes mellitus is increased.
Paul Feuerstadt, MD: The Value of Antimicrobial Stewardship for C Difficile
Dr. Feuerstadt presented data about RBX2660 during the recent ACG 2021 meeting.
William Chey, MD, Explores Integrated Care for IBS Treatment at ACG 2021
In his lecture, The End of the Beginning: Megatrends in Gastroenterology, William Chey, MD, emphasizes the importance of a multidisciplinary integrated care approach to treating IBS.
Marla C. Dubinsky, MD: Measuring Urgency in Ulcerative Colitis
An absence of urgency was associated with greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.
SER-109 Reduces Recurrence of C Difficile Infections
Approximately 88% of patients treated with SER-109 achieved a sustained clinical response at 8 weeks.
Jessica R Allegretti, MD, MPH: Preventing Recurrent C Difficile with CP101
A new study presented at ACG 2021 shows microbiome therapeutic CP101 effective in preventing recurrent CDI by increasing intestinal microbiome diversity.
Etrasimod Leads to Improvements in Quality of Life for Ulcerative Colitis Patients
Patients in the open-label extension of the OASIS study saw increases in Inflammatory Bowel Disease Questionnaire (IBDQ) scores.
Evan S. Dellon, MD: A Daily Diary for Eosinophilic Esophagitis
PROSE allows patients to report their symptoms of dysphagia in real-time.
Ji Seok Park, MD: Collaborating with Other Specialists for IBD Research
Investigators found fistulizing Crohn’s disease increases the healthcare burden and lengthens the duration of hospital stays in patients with acute kidney injuries.
James Izanec, MD, AGAF: Examining Quality of Life in Crohn's Disease Treatment
Biologic therapies show promising results of clinical remission in patients with Crohn's disease.
Paul Feuerstadt, MD: RBX2660 and FMT for C Difficile Infections
It can be challenging to find a suitable donor for fecal microbiota transplantation.
Rawan Aljaras, MD: The Impact of Diet on Patients with Irritable Bowel Syndrome
Dr. Aljaras talks about the importance of focusing on diet when examining irritable bowel syndrome.
Paul Feuerstadt, MD: The Promise of RBX2660 for C Difficile
RBX2660 is a a standardized, stabilized, investigational microbiota-based live therapeutic being studied for the treatment of C difficile infections.
Ji Seok Park, MD: The Connection Between Crohn's Disease and Kidney Disease
Patients with Crohn's disease often also suffer from kidney dysfunction.
Liver Transplant Recipients With Heart Failure Require More Attention
This patient group had higher odds of death and longer lengths of hospital stays.
Risankizumab Effective Treating Moderate-to-Severe Crohn’s Disease
Patients in both the ADVANCE and MOTIVATE studies achieved enhanced clinical response and endoscopic response.